Australia’s drug regulator, the Therapeutic Goods Administration (TGA), has added two new safety warnings about mental health and contraception for people taking weightloss drugs.
The TGA said that suicidal behaviour and ideation have been reported with these relatively new GLP-1 receptor agonists and, despite no proven causal association, they feel awareness and caution is needed.
Australian correspondent Murray Olds told Heather du Plessis-Allan, "There's still not a lot of information available. (Ozempic) hasn't been around long enough."
LISTEN ABOVE

Perspective with Heather du Plessis-Allan: The attention on the Waikato ED case could increase the odds of fixing the problem
02:06

Full Show Podcast: 03 July 2026
1:40:38

Perspective with Heather du Plessis-Allan: What real employer would do what the Ministry of Justice did?
02:25